Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giovanni Roveroni
Observed names:
G ROVERONI,
G Roveroni,
G. Roveroni,
Giovanni ROVERONI
Institutions:
Ospedale di Mirano,
Ospedale dell' Angelo
Observed institutions:
Semmelweis University,
University of Bern,
University of Padua,
Ospedale di Mirano,
Regione del Veneto,
Ospedale dell' Angelo,
Azienda Ospedale - Università Padova,
Otto-von-Guericke-Universität Magdeburg
show all 8
ORCID:
0000-0003-0107-9534
Observed ORCID:
0000-0003-0107-9534
OpenAlex ID:
A5043123902
The role of cysteine and serine proteases in colorectal carcinoma
1999
·
L�szl� Hersz�nyi
, Mario Plebani
, et al.
·
Cancer
·
110
PDF
Analysis of Helicobacter pylori vacA andcagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases
1998
·
D Basso
, F Navaglia
, et al.
·
Gut
·
85
PDF
Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias.
1997
·
P Fogar
, D Basso
, et al.
·
PubMed
·
67
Proteases in gastrointestinal neoplastic diseases
2000
·
László Herszényi
, Mario Plebani
, et al.
·
Clinica Chimica Acta
·
58
Cysteine and serine proteases in gastric cancer
1995
·
Mario Plebani
, Làszlò Herszènyi
, et al.
·
Cancer
·
55
PDF
CEA mRNA Identification in Peripheral Blood Is Feasible for Colorectal, But Not for Gastric or Pancreatic Cancer Staging
2000
·
Maria Grazia Piva
, Filippo Navaglia
, et al.
·
Oncology
·
54
Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role
1997
·
Mario Plebani
, Làszlo Herszènyi
, et al.
·
Clinical & Experimental Metastasis
·
43
Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis
1996
·
F. Farinati
, L. Herszènyi
, et al.
·
Carcinogenesis
·
43
Serum tumor markers in colorectal cancer staging, grading, and follow-up
1996
·
Mario Plebani
, Massimo De Paoli
, et al.
·
Journal of Surgical Oncology
·
33
Serum tumor markers in monitoring patients: interpretation of results using analytical and biological variation.
1996
·
M Plebani
, A Giacomini
, et al.
·
PubMed
·
27
The JAK2(V617F) tyrosine kinase mutation in blood donors with upper-limit haematocrit levels.
2009
·
Giuseppe Tagariello
, Rosanna Di Gaetano
, et al.
·
PubMed
·
14
Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies
2021
·
Giustina De Silvestro
, Giorgio Gandini
, et al.
·
Transfusion and Apheresis Science
·
7
PDF
Acquired haemophilia A as a blood transfusion emergency.
2008
·
Giuseppe Tagariello
, Roberto Sartori
, et al.
·
PubMed
·
7
Metastatic colorectal cancer stimulates collagen synthesis by fibroblasts.
2001
·
D Basso
, S Mazza
, et al.
·
PubMed
·
7
The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer.
1995
·
L Herszényi
, M Plebani
, et al.
·
PubMed
·
7
[Role and behavior of cathepsin B and cathepsin L in gastric cancer].
1995
·
L Herszényi
, M Plebani
, et al.
·
PubMed
·
6
Cysteine and serine proteases in colorectal cancer
1998
·
L. Herszényi
, M. Plebani
, et al.
·
Gastroenterology
·
5
PDF
N-terminal peptide of Type III procollagen: A possible predictor of colorectal carcinoma recurrence
1997
·
Mario Plebani
, Daniela Basso
, et al.
·
Cancer
·
5
PDF
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging
2000
·
M.G. Piva
, P. Fogar
, et al.
·
Digestive and Liver Disease
·
4
[Prognostic role of cisteine and serin proteases in gastriC cancer].
1996
·
L Herszényi
, F Farinati
, et al.
·
PubMed
·
3
Evaluation of Integrated Patient-Centered Model of Territorial Transfusion Medicine across Healthcare Settings: A Retrospective Study
2026
·
Gianluca Gessoni
, Giulia de Fusco
, et al.
·
International Blood Research & Reviews
·
1
Urokinase type plasminogen activator and inhibitor type-1 plasma levels in colorectal cancer
2001
·
L HERSZENYI
, F FARINATI
, et al.
·
Gastroenterology
·
1
Integrated Clinical, Respiratory and Biomarker Prediction of Mortality in Patients with Severe COVID-19 Pneumonia Treated with Convalescent Plasma: Development and Internal Validation of Prognostic Models
2026
·
Gianluca Gessoni
, Sara Valverde
, et al.
·
Asian Journal of Research in Infectious Diseases
Intravenous Iron Therapy in an Outpatient Setting in North-East Italy: A Pharmacoeconomic and Patient Blood Management Perspective
2026
·
Gianluca Gessoni
, Filippo Manfrin
, et al.
·
Therapeutics
Convalescent Plasma Infusion does not Appear to Change the Prognosis in Italian Patients Hospitalized with Sars-Cov-2 Pneumonia
2023
·
Gianluca Gessoni
, Giovanni Roveroni
, et al.
·
International Blood Research & Reviews
PDF
Show more works
View as search
Works count:
32
Citation count:
642
H-index:
11
I10-index:
11
Year
Topic
Type